A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

NCT01044108 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

117

Enrollment

INDUSTRY

Sponsor class

Stopped See detailed description

Conditions

Metabolism and Nutrition Disorder
Obesity

Interventions

DRUG: NNC 0070-0002-0453
DRUG: '2-0453
DRUG: placebo

Sponsor

Novo Nordisk A/S